Kadmon Stock Price, News & Analysis (NYSE:KDMN)

$3.76 +0.01 (+0.27 %)
(As of 02/22/2018 06:00 AM ET)
Previous Close$3.76
Today's Range$3.67 - $3.82
52-Week Range$2.05 - $5.86
Volume607,727 shs
Average Volume1.46 million shs
Market Capitalization$295.70 million
P/E Ratio-2.15
Dividend YieldN/A
BetaN/A

About Kadmon (NYSE:KDMN)

Kadmon logoKadmon Holdings, Inc. is an integrated biopharmaceutical company engaged in the discovery, development and commercialization of small molecules and biologics to address disease areas of various unmet medical needs. The Company is developing product candidates in a number of indications within autoimmune and fibrotic disease, oncology and genetic diseases. Its product pipeline consists of KD025, Tesevatinib and KD034. The Company's other products include Ribasphere RibaPak, Ribasphere, Qsymia, Tetrabenazine and Valganciclovir. KD025 is an orally available, selective small molecule inhibitor of Rho-associated coiled-coil kinase 2 (ROCK2), a molecular target in multiple autoimmune, fibrotic and neurodegenerative diseases. Tesevatinib is an oral tyrosine kinase inhibitor (TKI) designed to block key molecular drivers of tumor growth, metastases and drug resistance. KD034 is the Company's portfolio of enhanced formulations of trientine hydrochloride for the treatment of Wilson's disease.

Receive KDMN News and Ratings via Email

Sign-up to receive the latest news and ratings for KDMN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biopharmaceuticals
Sub-IndustryN/A
SectorHealthcare
SymbolNYSE:KDMN
CUSIPN/A
Phone+1-212-3086000

Debt

Debt-to-Equity RatioN/A
Current Ratio1.30%
Quick Ratio1.29%

Price-To-Earnings

Trailing P/E Ratio-2.14857142857143
Forward P/E Ratio-2.32
P/E GrowthN/A

Sales & Book Value

Annual Sales$26.06 million
Price / Sales11.35
Cash FlowN/A
Price / CashN/A
Book Value($1.41) per share
Price / Book-2.67

Profitability

Trailing EPS($1.75)
Net Income$-208,750,000.00
Net Margins-555.91%
Return on EquityN/A
Return on Assets-124.91%

Miscellaneous

Employees118
Outstanding Shares78,640,000

Kadmon (NYSE:KDMN) Frequently Asked Questions

What is Kadmon's stock symbol?

Kadmon trades on the New York Stock Exchange (NYSE) under the ticker symbol "KDMN."

How were Kadmon's earnings last quarter?

Kadmon Holdings Inc (NYSE:KDMN) released its quarterly earnings data on Thursday, November, 9th. The company reported ($0.42) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.38) by $0.04. The company had revenue of $2.28 million for the quarter, compared to analysts' expectations of $5.69 million. The company's revenue was down 60.0% compared to the same quarter last year. During the same period in the prior year, the firm posted ($4.24) EPS. View Kadmon's Earnings History.

Where is Kadmon's stock going? Where will Kadmon's stock price be in 2018?

5 brokerages have issued twelve-month target prices for Kadmon's shares. Their predictions range from $3.00 to $25.00. On average, they anticipate Kadmon's share price to reach $11.40 in the next year. View Analyst Ratings for Kadmon.

Who are some of Kadmon's key competitors?

When did Kadmon IPO?

(KDMN) raised $101 million in an initial public offering (IPO) on Wednesday, July 27th 2016. The company issued 5,600,000 shares at $16.00-$20.00 per share. Citigroup and Jefferies served as the underwriters for the IPO and JMP Securities and H.C. Wainwright & Co. were co-managers.

Who owns Kadmon stock?

Kadmon's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include GOLDENTREE ASSET MANAGEMENT LP (7.20%), Goldentree Asset Management LP (2.05%), Crestline Management LP (0.71%), Linden Advisors LP (0.67%), AE Wealth Management LLC (0.66%) and Geode Capital Management LLC (0.59%). Company insiders that own Kadmon stock include Bart M Schwartz, Daniel S Loeb, Eugene Bauer, Goldentree Asset Management Lp, Harlan Waksal, Konstantin Poukalov and Steven N Gordon. View Institutional Ownership Trends for Kadmon.

Who sold Kadmon stock? Who is selling Kadmon stock?

Kadmon's stock was sold by a variety of institutional investors in the last quarter, including Highland Capital Management LP, Linden Advisors LP, Millennium Management LLC and Crestline Management LP. View Insider Buying and Selling for Kadmon.

Who bought Kadmon stock? Who is buying Kadmon stock?

Kadmon's stock was bought by a variety of institutional investors in the last quarter, including Goldentree Asset Management LP, Geode Capital Management LLC, Spark Investment Management LLC, Sawtooth Solutions LLC, AE Wealth Management LLC, BlackRock Inc., BlueCrest Capital Management Ltd and Wells Fargo & Company MN. Company insiders that have bought Kadmon stock in the last two years include Bart M Schwartz, Daniel S Loeb, Eugene Bauer, Goldentree Asset Management Lp, Harlan Waksal, Konstantin Poukalov and Steven N Gordon. View Insider Buying and Selling for Kadmon.

How do I buy Kadmon stock?

Shares of Kadmon can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Kadmon's stock price today?

One share of Kadmon stock can currently be purchased for approximately $3.76.

How big of a company is Kadmon?

Kadmon has a market capitalization of $295.70 million and generates $26.06 million in revenue each year. The company earns $-208,750,000.00 in net income (profit) each year or ($1.75) on an earnings per share basis. Kadmon employs 118 workers across the globe.

How can I contact Kadmon?

Kadmon's mailing address is 450 E 29th St, NEW YORK, NY 10016-8367, United States. The company can be reached via phone at +1-212-3086000 or via email at [email protected]


MarketBeat Community Rating for Kadmon (KDMN)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  112 (Vote Outperform)
Underperform Votes:  89 (Vote Underperform)
Total Votes:  201
MarketBeat's community ratings are surveys of what our community members think about Kadmon and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Kadmon (NYSE:KDMN) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldBuy
Consensus Rating Score: 2.402.252.252.67
Ratings Breakdown: 1 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $11.40$9.75$9.75$9.85
Price Target Upside: 146.22% upside172.35% upside164.23% upside322.75% upside

Kadmon (NYSE:KDMN) Consensus Price Target History

Price Target History for Kadmon (NYSE:KDMN)

Kadmon (NYSE:KDMN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/13/2018Piper Jaffray CompaniesReiterated RatingOverweight -> Positive$7.00 -> $9.00HighView Rating Details
2/13/2018Jefferies GroupBoost Price TargetPositive -> Buy$16.00HighView Rating Details
12/15/2017HC WainwrightReiterated RatingBuy$25.00LowView Rating Details
10/9/2017WBB SecuritiesDowngradeHold -> Sell$3.00N/AView Rating Details
3/27/2017CitigroupLower Price TargetNeutral$6.00 -> $4.00HighView Rating Details
11/21/2016JMP SecuritiesReiterated RatingBuyN/AView Rating Details
(Data available from 2/22/2016 forward)

Earnings

Kadmon (NYSE:KDMN) Earnings History and Estimates Chart

Earnings by Quarter for Kadmon (NYSE:KDMN)

Kadmon (NYSE KDMN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/9/2017Q3 2017($0.38)($0.42)$5.69 million$2.28 millionViewN/AView Earnings Details
8/3/2017Q2 2017($0.49)($0.44)$3.46 million$3.00 millionViewN/AView Earnings Details
5/15/2017Q1 2017($0.52)($0.39)$4.25 million$5.60 millionViewN/AView Earnings Details
3/22/2017Q4 2016($0.71)($0.50)$4.50 million$4.28 millionViewN/AView Earnings Details
11/9/2016Q3 2016($0.40)($4.23)$3.90 million$5.70 millionViewN/AView Earnings Details
9/7/2016Q2 2016($0.88)($4.42)$6.48 million$6.42 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Kadmon (NYSE:KDMN) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q4 20181($0.53)($0.53)($0.53)
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Kadmon (NYSE:KDMN)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Kadmon (NYSE KDMN) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 8.41%
Institutional Ownership Percentage: 53.27%
Insider Trades by Quarter for Kadmon (NYSE:KDMN)
Institutional Ownership by Quarter for Kadmon (NYSE:KDMN)

Kadmon (NYSE KDMN) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/6/2017Goldentree Asset Management LpMajor ShareholderSell302,950$2.73$827,053.50View SEC Filing  
8/10/2017Harlan WaksalCEOBuy5,000$2.27$11,350.00110,747View SEC Filing  
8/8/2017Eugene BauerDirectorBuy5,000$2.36$11,800.001,716View SEC Filing  
8/8/2017Harlan WaksalCEOBuy3,707$2.34$8,674.38105,747View SEC Filing  
8/8/2017Steven N. GordonVPBuy1,000$2.47$2,470.00View SEC Filing  
7/31/2017Goldentree Asset Management LpMajor ShareholderSell349,661$2.60$909,118.60View SEC Filing  
7/11/2017Goldentree Asset Management LpMajor ShareholderSell34,462$3.69$127,164.78View SEC Filing  
6/29/2017Goldentree Asset Management LpMajor ShareholderSell64,375$4.04$260,075.00View SEC Filing  
6/27/2017Goldentree Asset Management LpMajor ShareholderSell108,827$3.69$401,571.63View SEC Filing  
6/26/2017Goldentree Asset Management LpMajor ShareholderSell515,643$3.51$1,809,906.93View SEC Filing  
6/22/2017Goldentree Asset Management LpMajor ShareholderSell767,363$3.50$2,685,770.50View SEC Filing  
3/13/2017Daniel S LoebMajor ShareholderBuy1,488,095$3.36$4,999,999.20View SEC Filing  
11/16/2016Harlan WaksalCEOBuy2,000$6.37$12,740.00102,040View SEC Filing  
11/14/2016Harlan WaksalCEOBuy2,000$6.79$13,580.00100,040View SEC Filing  
11/11/2016Konstantin PoukalovCFOBuy4,000$5.81$23,240.001,000View SEC Filing  
9/14/2016Daniel S LoebMajor ShareholderBuy19,611$7.79$152,769.69View SEC Filing  
9/13/2016Daniel S LoebMajor ShareholderBuy68,654$8.33$571,887.82View SEC Filing  
9/6/2016Daniel S LoebMajor ShareholderBuy81,781$9.39$767,923.59View SEC Filing  
8/26/2016Daniel S LoebMajor ShareholderBuy32,916$9.98$328,501.68View SEC Filing  
8/22/2016Daniel S LoebMajor ShareholderBuy11,305$10.00$113,050.00View SEC Filing  
8/15/2016Daniel S LoebMajor ShareholderBuy6,010$9.95$59,799.50View SEC Filing  
8/12/2016Daniel S LoebMajor ShareholderBuy87,529$9.98$873,539.42View SEC Filing  
8/5/2016Daniel S LoebMajor ShareholderBuy66,828$9.94$664,270.32View SEC Filing  
8/3/2016Daniel S LoebMajor ShareholderBuy1,431,996$11.35$16,253,154.60View SEC Filing  
8/1/2016Goldentree Asset Management LpMajor ShareholderBuy208,333$12.00$2,499,996.00View SEC Filing  
7/28/2016Bart M SchwartzDirectorBuy2,000$9.77$19,540.0026,211View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Kadmon (NYSE KDMN) News Headlines

Source:
DateHeadline
Kadmon (KDMN) PT Raised to $16.00 at Jefferies GroupKadmon (KDMN) PT Raised to $16.00 at Jefferies Group
www.americanbankingnews.com - February 18 at 8:10 PM
$3.72 Million in Sales Expected for Kadmon Holdings Inc (KDMN) This Quarter$3.72 Million in Sales Expected for Kadmon Holdings Inc (KDMN) This Quarter
www.americanbankingnews.com - February 17 at 6:42 AM
Kadmon Holdings Inc to Post FY2021 Earnings of ($2.83) Per Share, Jefferies Group Forecasts (KDMN)Kadmon Holdings Inc to Post FY2021 Earnings of ($2.83) Per Share, Jefferies Group Forecasts (KDMN)
www.americanbankingnews.com - February 15 at 4:10 PM
-$0.34 EPS Expected for Kadmon Holdings Inc (KDMN) This Quarter-$0.34 EPS Expected for Kadmon Holdings Inc (KDMN) This Quarter
www.americanbankingnews.com - February 15 at 11:10 AM
Kadmon (KDMN) Reports Positive Topline Results from Phase 2 Study of KD025 in Idiopathic Pulmonary FibrosisKadmon (KDMN) Reports Positive Topline Results from Phase 2 Study of KD025 in Idiopathic Pulmonary Fibrosis
www.streetinsider.com - February 14 at 9:07 AM
Why Molina Healthcare, Brighthouse Financial, and Kadmon Holdings Slumped TodayWhy Molina Healthcare, Brighthouse Financial, and Kadmon Holdings Slumped Today
finance.yahoo.com - February 14 at 9:07 AM
Why Karmon's "Positive" Data Turned Into a 21% DeclineWhy Karmon's "Positive" Data Turned Into a 21% Decline
finance.yahoo.com - February 14 at 9:07 AM
Vertex Pharmaceuticals, Kadmon Holdings Are Early Week Biotech MoversVertex Pharmaceuticals, Kadmon Holdings Are Early Week Biotech Movers
finance.yahoo.com - February 13 at 4:28 PM
Kadmon (KDMN) Receives "Positive" Rating from Piper Jaffray CompaniesKadmon (KDMN) Receives "Positive" Rating from Piper Jaffray Companies
www.americanbankingnews.com - February 13 at 11:12 AM
BRIEF-Kadmon Posts Positive Topline Results From Phase 2 Study Of KD025 In Idiopathic Pulmonary FibrosisBRIEF-Kadmon Posts Positive Topline Results From Phase 2 Study Of KD025 In Idiopathic Pulmonary Fibrosis
www.reuters.com - February 13 at 9:05 AM
After-Hours Stock Movers 02/12: (KDMN) (VIPS) (RNG) Higher; (HMNY) (AFMD) (moh) Lower (more...)After-Hours Stock Movers 02/12: (KDMN) (VIPS) (RNG) Higher; (HMNY) (AFMD) (moh) Lower (more...)
www.streetinsider.com - February 13 at 9:05 AM
Kadmon to Host Webcast and Conference Call to Discuss Topline Results of KD025 in IPFKadmon to Host Webcast and Conference Call to Discuss Topline Results of KD025 in IPF
finance.yahoo.com - February 13 at 9:05 AM
Kadmon Announces Positive Topline Results from Phase 2 Study of KD025 in Idiopathic Pulmonary FibrosisKadmon Announces Positive Topline Results from Phase 2 Study of KD025 in Idiopathic Pulmonary Fibrosis
finance.yahoo.com - February 12 at 4:34 PM
Major Biopharma Catalysts on February’s FDA CalendarMajor Biopharma Catalysts on February’s FDA Calendar
247wallst.com - February 3 at 9:01 AM
Kadmon Holdings Inc (KDMN) Receives Average Recommendation of "Hold" from AnalystsKadmon Holdings Inc (KDMN) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - February 2 at 7:22 PM
Kadmon Holdings Inc (KDMN) to Post FY2022 Earnings of ($1.58) Per Share, Jefferies Group ForecastsKadmon Holdings Inc (KDMN) to Post FY2022 Earnings of ($1.58) Per Share, Jefferies Group Forecasts
www.americanbankingnews.com - January 29 at 9:10 AM
Kadmon Holdings (KDMN) Jumps: Stock Rises 9.3% - NasdaqKadmon Holdings (KDMN) Jumps: Stock Rises 9.3% - Nasdaq
www.nasdaq.com - January 15 at 4:13 PM
Kadmon Holdings (KDMN) Jumps: Stock Rises 9.3%Kadmon Holdings (KDMN) Jumps: Stock Rises 9.3%
finance.yahoo.com - January 15 at 10:33 AM
Kadmon (KDMN) Lifted to "Buy" at Zacks Investment ResearchKadmon (KDMN) Lifted to "Buy" at Zacks Investment Research
www.americanbankingnews.com - January 14 at 8:10 PM
Reviewing Alimera Sciences (ALIM) and Kadmon (KDMN)Reviewing Alimera Sciences (ALIM) and Kadmon (KDMN)
www.americanbankingnews.com - January 14 at 7:34 AM
Kadmon Holdings Inc (KDMN) Expected to Announce Earnings of -$0.34 Per ShareKadmon Holdings Inc (KDMN) Expected to Announce Earnings of -$0.34 Per Share
www.americanbankingnews.com - January 12 at 1:04 PM
Kadmon Holdings Inc (KDMN) Given Consensus Recommendation of "Hold" by BrokeragesKadmon Holdings Inc (KDMN) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - January 8 at 10:02 PM
KDMN And 10 Other Biotech Stocks You Should Watch This MonthKDMN And 10 Other Biotech Stocks You Should Watch This Month
www.nasdaq.com - January 2 at 4:51 PM
$4.07 Million in Sales Expected for Kadmon Holdings Inc (KDMN) This Quarter$4.07 Million in Sales Expected for Kadmon Holdings Inc (KDMN) This Quarter
www.americanbankingnews.com - December 28 at 2:12 AM
Kadmon Holdings Inc (KDMN) to Post FY2017 Earnings of ($1.73) Per Share, Jefferies Group ForecastsKadmon Holdings Inc (KDMN) to Post FY2017 Earnings of ($1.73) Per Share, Jefferies Group Forecasts
www.americanbankingnews.com - December 25 at 2:28 AM
Financial Analysis: Novus Therapeutics (NVUS) & Kadmon (KDMN)Financial Analysis: Novus Therapeutics (NVUS) & Kadmon (KDMN)
www.americanbankingnews.com - December 23 at 3:07 AM
ETFs with exposure to Kadmon Holdings, Inc. : December 20, 2017ETFs with exposure to Kadmon Holdings, Inc. : December 20, 2017
finance.yahoo.com - December 20 at 4:10 PM
Syndax Pharmaceuticals (SNDX) versus Kadmon (KDMN) Financial AnalysisSyndax Pharmaceuticals (SNDX) versus Kadmon (KDMN) Financial Analysis
www.americanbankingnews.com - December 20 at 11:28 AM
Kadmon (KDMN) Stock Rating Reaffirmed by HC WainwrightKadmon (KDMN) Stock Rating Reaffirmed by HC Wainwright
www.americanbankingnews.com - December 15 at 2:56 PM
Kadmon Holdings, Inc. (KDMN) Given Consensus Rating of "Hold" by BrokeragesKadmon Holdings, Inc. (KDMN) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - December 14 at 11:58 PM
Kadmon (KDMN) & The Competition Head to Head ReviewKadmon (KDMN) & The Competition Head to Head Review
www.americanbankingnews.com - December 14 at 7:16 AM
Kadmon (KDMN) versus Its Peers Critical ComparisonKadmon (KDMN) versus Its Peers Critical Comparison
www.americanbankingnews.com - December 12 at 11:07 AM
Head-To-Head Survey: Kadmon (KDMN) & Its RivalsHead-To-Head Survey: Kadmon (KDMN) & Its Rivals
www.americanbankingnews.com - December 12 at 7:56 AM
Kadmon (KDMN) Announces Updated Positive Phase 2 Data on KD025 in cGVHD - StreetInsider.comKadmon (KDMN) Announces Updated Positive Phase 2 Data on KD025 in cGVHD - StreetInsider.com
www.streetinsider.com - December 11 at 11:27 AM
Zacks: Analysts Expect Kadmon Holdings, Inc. (KDMN) Will Post Quarterly Sales of $4.07 MillionZacks: Analysts Expect Kadmon Holdings, Inc. (KDMN) Will Post Quarterly Sales of $4.07 Million
www.americanbankingnews.com - December 11 at 10:52 AM
Kadmon (KDMN) versus Its Peers Financial ContrastKadmon (KDMN) versus Its Peers Financial Contrast
www.americanbankingnews.com - December 10 at 11:32 PM
Kadmon Presents Updated Positive Phase 2 Data on KD025 in cGVHD at ASH Annual MeetingKadmon Presents Updated Positive Phase 2 Data on KD025 in cGVHD at ASH Annual Meeting
finance.yahoo.com - December 10 at 10:34 AM
-$0.34 EPS Expected for Kadmon Holdings, Inc. (KDMN) This Quarter-$0.34 EPS Expected for Kadmon Holdings, Inc. (KDMN) This Quarter
www.americanbankingnews.com - December 9 at 9:30 AM
Kadmon (KDMN) & Its Rivals Critical ReviewKadmon (KDMN) & Its Rivals Critical Review
www.americanbankingnews.com - December 5 at 3:32 AM
Head to Head Survey: Baxalta (BXLT) vs. Kadmon (KDMN)Head to Head Survey: Baxalta (BXLT) vs. Kadmon (KDMN)
www.americanbankingnews.com - December 1 at 11:38 AM
ETFs with exposure to Kadmon Holdings, Inc. : November 30, 2017ETFs with exposure to Kadmon Holdings, Inc. : November 30, 2017
finance.yahoo.com - November 30 at 4:11 PM
Financial Comparison: Kadmon (KDMN) and The CompetitionFinancial Comparison: Kadmon (KDMN) and The Competition
www.americanbankingnews.com - November 30 at 3:36 PM
Kadmon Holdings, Inc. :KDMN-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017Kadmon Holdings, Inc. :KDMN-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017
finance.yahoo.com - November 29 at 10:52 AM
Kadmon to Present at the 29th Annual Piper Jaffray Healthcare ConferenceKadmon to Present at the 29th Annual Piper Jaffray Healthcare Conference
finance.yahoo.com - November 27 at 5:15 PM
Analyzing Kadmon (KDMN) and Its PeersAnalyzing Kadmon (KDMN) and Its Peers
www.americanbankingnews.com - November 27 at 5:28 AM
Kadmon Holdings (KDMN) vs. Its Peers Critical SurveyKadmon Holdings (KDMN) vs. Its Peers Critical Survey
www.americanbankingnews.com - November 25 at 9:26 AM
$4.07 Million in Sales Expected for Kadmon Holdings, Inc. (KDMN) This Quarter$4.07 Million in Sales Expected for Kadmon Holdings, Inc. (KDMN) This Quarter
www.americanbankingnews.com - November 23 at 10:34 AM
Reviewing Kadmon Holdings (KDMN) and 3SBio (SSRX)Reviewing Kadmon Holdings (KDMN) and 3SBio (SSRX)
www.americanbankingnews.com - November 22 at 7:42 PM
Head to Head Contrast: Kadmon Holdings (KDMN) vs. Its PeersHead to Head Contrast: Kadmon Holdings (KDMN) vs. Its Peers
www.americanbankingnews.com - November 22 at 3:42 PM
Kadmon Holdings, Inc. (KDMN) Upgraded to "Hold" by Zacks Investment ResearchKadmon Holdings, Inc. (KDMN) Upgraded to "Hold" by Zacks Investment Research
www.americanbankingnews.com - November 22 at 12:56 AM

SEC Filings

Kadmon (NYSE:KDMN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Kadmon (NYSE:KDMN) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Kadmon (NYSE KDMN) Stock Chart for Thursday, February, 22, 2018

Loading chart…

This page was last updated on 2/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.